JP2002522021A5 - - Google Patents

Info

Publication number

JP2002522021A5

JP2002522021A5 JP2000561317A JP2000561317A JP2002522021A5 JP 2002522021 A5 JP2002522021 A5 JP 2002522021A5 JP 2000561317 A JP2000561317 A JP 2000561317A JP 2000561317 A JP2000561317 A JP 2000561317A JP 2002522021 A5 JP2002522021 A5 JP 2002522021A5

Authority

JP

Japan

Prior art keywords

polypeptide

seq

polynucleotide

nucleotide sequence

amino acid

Prior art date

1999-07-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 description 100
• 229920001184 polypeptide Polymers 0.000 description 99
• 102000004196 processed proteins & peptides Human genes 0.000 description 99
• 108091033319 polynucleotide Proteins 0.000 description 36
• 102000040430 polynucleotide Human genes 0.000 description 36
• 239000002157 polynucleotide Substances 0.000 description 36
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 33
• 238000000034 method Methods 0.000 description 31
• 239000002773 nucleotide Substances 0.000 description 29
• 125000003729 nucleotide group Chemical group 0.000 description 29
• 210000004027 cell Anatomy 0.000 description 20
• 125000000539 amino acid group Chemical group 0.000 description 17
• 150000007523 nucleic acids Chemical group 0.000 description 11
• 125000003275 alpha amino acid group Chemical group 0.000 description 9
• 239000005557 antagonist Substances 0.000 description 9
• 239000002299 complementary DNA Substances 0.000 description 9
• 102000039446 nucleic acids Human genes 0.000 description 9
• 108020004707 nucleic acids Proteins 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 7
• 239000000203 mixture Substances 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 230000000694 effects Effects 0.000 description 4
• 230000014509 gene expression Effects 0.000 description 4
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108091028043 Nucleic acid sequence Proteins 0.000 description 3
• 239000000556 agonist Substances 0.000 description 3
• 150000001413 amino acids Chemical class 0.000 description 3
• 108091008324 binding proteins Proteins 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 241000588724 Escherichia coli Species 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 239000012634 fragment Substances 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1